{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:38:41Z","timestamp":1759963121653},"reference-count":30,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.vaccine.2005.03.015","type":"journal-article","created":{"date-parts":[[2005,4,16]],"date-time":"2005-04-16T11:28:33Z","timestamp":1113650913000},"page":"4136-4141","source":"Crossref","is-referenced-by-count":16,"title":["Identification of novel antigens that protect against systemic meningococcal infection"],"prefix":"10.1016","volume":"23","author":[{"given":"Yaohui","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M.","family":"Exley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Winterbotham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Ison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph M.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.03.015_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/35006546","article-title":"ABC of meningococcal diversity","volume":"404","author":"Feavers","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2005.03.015_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144-166.2000","article-title":"Update on meningococcal disease with emphasis on pathogenesis and clinical management","volume":"13","author":"van Deuren","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2005.03.015_bib3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants","volume":"174","author":"Fairley","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.015_bib4","first-page":"49","article-title":"Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales","volume":"7","author":"Ramsay","year":"1997","journal-title":"Commun Dis Rep CDR Rev"},{"key":"10.1016\/j.vaccine.2005.03.015_bib5","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.03.015_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.015_bib7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(02)08416-7","article-title":"Development of vaccines against meningococcal disease","volume":"359","author":"Jodar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2005.03.015_bib8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1086\/368360","article-title":"Highly conserved Neisseria meningitidis inner-core lipopolysaccharide epitope confers protection against experimental meningococcal bacteremia","volume":"187","author":"Plested","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.015_bib9","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","article-title":"Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing","volume":"287","author":"Pizza","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.03.015_bib10","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/81380","article-title":"Functional genomics of Neisseria meningitidis pathogenesis","volume":"6","author":"Sun","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2005.03.015_bib13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1126\/science.287.5459.1809","article-title":"Complete genome sequence of Neisseria meningitidis serogroup B strain MC58","volume":"287","author":"Tettelin","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2005.03.015_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1111\/j.1365-2958.1991.tb00807.x","article-title":"The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells","volume":"5","author":"Virji","year":"1991","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.03.015_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/IAI.72.1.345-351.2004","article-title":"Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live meningococci","volume":"72","author":"Li","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.micro.53.1.129","article-title":"In vivo genetic analysis of bacterial virulence","volume":"53","author":"Chiang","year":"1999","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2005.03.015_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2958.1997.3421692.x","article-title":"Cloning and functional characterization of Neisseria gonorrhoeae tonB, exbB and exbD genes","volume":"24","author":"Biswas","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2005.03.015_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1128\/jb.179.3.805-812.1997","article-title":"Neisseria meningitidis tonB, exbB, and exbD genes: Ton-dependent utilization of protein-bound iron in Neisseriae","volume":"179","author":"Stojiljkovic","year":"1997","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2005.03.015_bib19","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1073\/pnas.95.6.3140","article-title":"Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms","volume":"95","author":"Maiden","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2005.03.015_bib20","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1084\/jem.185.7.1173","article-title":"Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection","volume":"185","author":"Martin","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.03.015_bib21","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib22","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","article-title":"Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans","volume":"66","author":"Haneberg","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib23","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/IAI.63.12.4642-4652.1995","article-title":"Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine","volume":"63","author":"Rosenqvist","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib24","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2005.03.015_bib25","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/IAI.70.7.3621-3626.2002","article-title":"Neisseria lactamica protects against experimental meningococcal infection","volume":"70","author":"Oliver","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib26","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.015_bib27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/315833","article-title":"Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States","volume":"182","author":"Sacchi","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.03.015_bib28","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1128\/IAI.68.12.6685-6690.2000","article-title":"Multiple mechanisms of phase variation of PorA in Neisseria meningitidis","volume":"68","author":"van der Ende","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.03.015_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35006655","article-title":"Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491","volume":"404","author":"Parkhill","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2005.03.015_bib30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nbt728","article-title":"Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays","volume":"20","author":"Grifantini","year":"2002","journal-title":"Nat Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05003944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:42:22Z","timestamp":1683070942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05003944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":30,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0264410X05003944"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.03.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}